Mirum Pharmaceuticals Inc
MIRM
Market Cap$2.49B
Close$
$27.50
45.6% downside
Current Fair Value
45.6% downsideOvervalued by 45.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.49 Billion |
|---|---|
| Enterprise Value | $2.60 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.85 |
| Beta | 0.95 |
| Outstanding Shares | 48,889,058 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -31.82 |
|---|---|
| PEG | 75.87 |
| Price to Sales | 7.22 |
| Price to Book Ratio | 12.64 |
| Enterprise Value to Revenue | 6.85 |
| Enterprise Value to EBIT | -38.36 |
| Enterprise Value to Net Income | -34 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 1.36 |
Revenue Sources
No data
Insider Trades
ESG Score
No data